ROCHE HOLDING AG News

Roche (RHHBY.US) has received approval for Roctavian in China for the treatment of relapsing and primary progressive multiple sclerosis.

Roche Pharmaceuticals (RHHBY.US) announced that its Innovative Drug Ocrevus (generic name: ocrelizumab injection) has officially been approved by the National Medical Products Administration of China.

Zhitong FinanceMar 31 09:19 ET

Trump's Medical Tariffs Could Significantly Hurt These European Healthcare Firms

Seeking AlphaMar 29 11:38 ET

ROCHE HOLDING AG To Go Ex-Dividend On March 28th, 2025 With 1.36297 USD Dividend Per Share

Moomoo NewsMar 26 21:00 ET

Marty Makary and Jay Bhattacharya Clear Senate Hurdles to Lead FDA and NIH

Seeking AlphaMar 26 06:56 ET

AlphaValue/Baader Europe Raises Roche Price Target on 'Healthy' Growth Prospects

MT NewswiresMar 26 06:39 ET · Ratings

Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding AG (OtherRHHVF), Kezar Life Sciences (KZR) and Axsome Therapeutics (AXSM)

TipRanksMar 26 04:50 ET · Ratings

Roche Poised For Growth Amid Obesity-Drug Ambitions -- Market Talk

WSJMar 26 04:49 ET

How to Play SRPT Stock After Patient Death Post DMD Therapy Infusion

Zacks Mar 24 08:35 ET

Merck's Keytruda Receives Traditional Approval for Type of Gastric Cancer

Seeking AlphaMar 19 14:05 ET

Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

BenzingaMar 19 13:09 ET

Roche Re-Scopes Chief Diversity Offices to Comply With US Executive Orders on Diversity, Equity, Inclusion

MT NewswiresMar 19 09:25 ET

Trump's DEI Battle Goes Global as Swiss Drugs Group Roche (RHHBY) Terminates Targets

TipRanksMar 19 08:44 ET

Market Chatter: Roche Reportedly Scraps Global Diversity Targets

MT NewswiresMar 19 08:18 ET

Roche, Oxford BioTherapeutics Team Up for Antibody-based Cancer Therapy Development

MT NewswiresMar 19 05:55 ET

Roche Holding AG (RHHVF) Receives a Buy From Kepler Capital

TipRanksMar 18 21:37 ET · Ratings

Sarepta Safety Update on Elevidys Boosts Regenxbio, Hurts Solid Bio

Seeking AlphaMar 18 15:22 ET

Sarepta Plunges After Death Linked to Elevidys

Seeking AlphaMar 18 08:17 ET

Roche (RHHBY.US) oral PI3Kα inhibitor "Inalise" has been approved for sale in China.

On March 14, Roche (RHHBY.US) announced that the PI3Kα inhibitor "Inalise" has been approved for market.

Zhitong FinanceMar 13 22:49 ET

NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand

Zacks Mar 13 13:20 ET

FDA Commissioner Nominee Makary Advances to Full Senate Vote

Seeking AlphaMar 13 10:58 ET